Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. Issue 7364 (14th September 2002)

• Record Type: Journal Article
• Authors: Pukkala, Eero; Aspholm, Rafael; Auvinen, Anssi; Eliasch, Harald; Gundestrup, Maryanne; Haldorsen, Tor; Hammar, Niklas; Hrafnkelsson, Jón; Kyyrönen, Pentti; Linnersjö, Anette; Rafnsson, Vilhjálmur; Storm, Hans; Tveten, Ulf
• Is Part Of: BMJ. Volume 325:Issue 7364(2002)
• Page Start: 567
• Publication Date: 2002-09-14
• Subjects: Medicine -- Periodicals; Medicine -- Periodicals; Medicine; Periodicals; 610
• DOI: 10.1136/bmj.325.7364.567
• Languages: English
• ISSNs: 0007-1447

Abstract

Abstract: Objective: To assess the incidence of cancer among male airline pilots in the Nordic countries, with special reference to risk related to cosmic radiation. Design: Retrospective cohort study, with follow up of cancer incidence through the national cancer registries. Setting: Denmark, Finland, Iceland, Norway, and Sweden. Participants: 10 032 male airline pilots, with an average follow up of 17 years. Main outcome measures: Standardised incidence ratios, with expected numbers based on national cancer incidence rates; dose-response analysis using Poisson regression. Results: 466 cases of cancer were diagnosed compared with 456 expected. The only significantly increased standardised incidence ratios were for skin cancer: melanoma 2.3 (95% confidence interval 1.7 to 3.0), non-melanoma 2.1 (1.7 to 2.8), basal cell carcinoma 2.5 (1.9 to 3.2). The relative risk of skin cancers increased with the estimated radiation dose. The relative risk of prostate cancer increased with increasing number of flight hours in long distance aircraft. Conclusions: This study does not indicate a marked increase in cancer risk attributable to cosmic radiation, although some influence of cosmic radiation on skin cancer cannot be entirely excluded. The suggestion of an association between number of long distance flights (possibly related to circadian hormonal disturbances) and prostate cancer needs to be confirmed.